Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach (Q4644003): Difference between revisions
From MaRDI portal
Set profile property. |
Set OpenAlex properties. |
||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1002/mma.4745 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2790814079 / rank | |||
Normal rank | |||
Latest revision as of 18:31, 19 March 2024
scientific article; zbMATH DE number 6876307
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach |
scientific article; zbMATH DE number 6876307 |
Statements
Optimal duration and dosage of BCG intravesical immunotherapy: A free final time optimal control approach (English)
0 references
30 May 2018
0 references
BCG immunotherapy
0 references
bladder cancer
0 references
final gain function
0 references
free final time
0 references
maximum principle
0 references
optimal control
0 references
